Investing.com - J&J (NYSE: JNJ) reported fourth quarter EPS of $2.04, $0.02 better than the analyst estimate of $2.02. Revenue for the quarter came in at $22.52B versus the consensus estimate of $22.46B.
Guidance
J&J sees FY 2025 EPS of $10.50-$10.70 versus the analyst consensus of $10.60.
J&J’s stock price closed at $148.15. It is down -7.91% in the last 3 months and down -7.30% in the last 12 months.
J&J saw 3 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See J&J’s stock price’s past reactions to earnings here.
According to InvestingPro, J&J’s Financial Health score is "good performance".
Check out J&J’s recent earnings performance, and J&J’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar